Sr One Capital Partners I, LP

SEC CIK: 0001853724

SEC filings (opens in a new tab)

No open-market purchases or sales filed in the past year.

Current role at each company

EFTR eFFECTOR Therapeutics, Inc.10% Owneras of Nov 29, 2023
ACLX Arcellx, Inc.10% Owneras of May 15, 2023
DSGN Design Therapeutics, Inc.10% Owneras of Dec 20, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: –; 0 filings
Net: –; Bought minus sold
Companies: 0; With open-market trades

Trades

Every Form 4 that lists Sr One Capital Partners I, LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

EFTR eFFECTOR Therapeutics, Inc.

10% Owner1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 29, 2023 (view filing)5:07 PM ET	Nov 27	2 days	George Simeon and 5 others10% Owner	SSale	−609.2K	$0.6065	−$369.5K	−25.1%1.82M after	2 lots

ACLX Arcellx, Inc.

10% Owner2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
May 15, 2023 (view filing)6:16 PM ET	May 11	4 days	George Simeon and 5 others10% Owner	SSale	−1.01M	$45.01	−$45.6M	−37.9%1.66M after	4 lots
Feb 10, 2022 (view filing)8:41 AM ET	Feb 8	2 days	George Simeon and 5 others10% Owner	PPurchase	+1.67M	$15.00	+$25.0M	+454.7%2.03M after	2 lotsDuplicate filing

DSGN Design Therapeutics, Inc.